Singapore, Aug 31, 2010: US based ThermoGenesis, a supplier of products that process and store adult stem cells, said it has sold two BioArchive systems to HealthBanks, which operates cord blood banks in Taiwan, Hong Kong and Thailand

HealthBanks now has a total of 20 BioArchives and a storage capacity for cryopreserving and archiving cord blood stem cells of 60,000 units. HealthBanks also utilizes ThermoGenesis' AXP AutoXpress (AXP) Platform, an automated device used for the processing of cord blood.

"We are pleased with our continued strengthening relationship with HealthBanks, as well as with the increased penetration in Asia. The region represents an important market opportunity for the Company as cord blood collection activity there is experiencing dramatic growth," noted J. Melville Engle, Chief Executive Officer of ThermoGenesis.

"We believe that the high cell recovery and viability achieved with the combined use of the AXP and BioArchive Systems plays a significant role in accelerating the time to patient engraftment," according to HealthBank's President Chang Hsiu-kang and Vice President of Operations Chen, Wei-Chun.

"As we announced previously, the prior quarter was marked by strong BioArchive activity and we are encouraged that this trend appears to be continuing in the current quarter as well," he added.